Docebo (DCBO) Cash & Equivalents (2019 - 2026)

Docebo (DCBO) has 8 years of Cash & Equivalents data on file, last reported at $63.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 31.72% year-over-year to $63.2 million; the trailing twelve-month figure through Mar 2026 stood at $63.2 million (down 31.72% YoY), and the FY2025 full-year result was $74.0 million, down 19.99% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $63.2 million, down from $74.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $216.3 million in Q4 2022 and bottomed at $63.2 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $92.5 million (2024), against an average of $130.1 million.
• The widest annual swing landed in 2023, when Cash & Equivalents sank 66.73%; it then grew 28.62% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $216.3 million in 2022, then sank by 66.73% to $72.0 million in 2023, then increased by 28.62% to $92.5 million in 2024, then decreased by 19.99% to $74.0 million in 2025, then declined by 14.65% to $63.2 million in 2026.
• The last three Cash & Equivalents figures came in at $63.2 million (Q1 2026), $74.0 million (Q4 2025), and $66.1 million (Q3 2025), per Business Quant data.

Peer Comparison